Antioxidants in Hops: Bioavailability, Health Effects and Perspectives for New Products

CA Zugravu, RE Bohiltea, T Salmen, E Pogurschi… - Antioxidants, 2022 - mdpi.com
Hop plant (Humulus lupulus L.) has been used by humans for ages, presumably first as a
herbal remedy, then in the manufacturing of different products, from which beer is the most …

Bile acid metabolism and signaling: emerging pharmacological targets of dietary polyphenols

KM Tveter, E Mezhibovsky, Y Wu… - Pharmacology & …, 2023 - Elsevier
Beyond their role as emulsifiers of lipophilic compounds, bile acids (BAs) are signaling
endocrine molecules that show differential affinity and specificity for a variety of canonical …

Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome

NK Newman, Y Zhang, J Padiadpu, CL Miranda… - Microbiome, 2023 - Springer
Background The gut microbiota contributes to macrophage-mediated inflammation in
adipose tissue with consumption of an obesogenic diet, thus driving the development of …

Gut enterotype-dependent modulation of gut microbiota and their metabolism in response to xanthohumol supplementation in healthy adults

PE Jamieson, EB Smart, JA Bouranis, J Choi… - Gut …, 2024 - Taylor & Francis
Xanthohumol (XN), a polyphenol found in the hop plant (Humulus lupulus), has antioxidant,
anti-inflammatory, prebiotic, and anti-hyperlipidemic activity. Preclinical evidence suggests …

Dietary polyphenols maintain homeostasis via regulating bile acid metabolism: a review of possible mechanisms

Y Liu, K Huang, Y Zhang, H Cao, X Guan - Food & Function, 2023 - pubs.rsc.org
The synthesis and metabolism of bile acids (BAs) has been implicated in various metabolic
diseases, including obesity and diabetes. As natural antioxidants, dietary polyphenols play a …

Xanthohumol Requires the Intestinal Microbiota to Improve Glucose Metabolism in Diet‐Induced Obese Mice

IE Logan, N Shulzhenko, TJ Sharpton… - Molecular nutrition & …, 2021 - Wiley Online Library
Scope The polyphenol xanthohumol (XN) improves dysfunctional glucose and lipid
metabolism in diet‐induced obesity animal models. Because XN changes intestinal …

Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2/RAGE/NF-κB signaling pathway

W Wang, Z Chen, T Zheng, M Zhang - Future Medicinal Chemistry, 2021 - Taylor & Francis
Hyperglycemia-associated advanced glycation end products (AGEs) and the receptor for
AGE (RAGE) contribute to nonalcoholic fatty liver disease (NAFLD). Xanthohumol (XH) …

Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial

BO Langley, JJ Ryan, J Phipps, L Buttolph, B Bray… - Trials, 2022 - Springer
Background Xanthohumol (XN), a bioactive flavonoid from Humulus lupulus with anti-
inflammatory properties, has potential benefits for patients with Crohn's disease (CD), a type …

Bile acid–induced metabolic changes in the colon promote Enterobacteriaceae expansion and associate with dysbiosis in Crohn's disease

R Holani, H Bar-Yoseph, Z Krekhno… - Science …, 2024 - science.org
Bile acids (BAs) affect the growth of potentially pathogenic commensals, including those
from the Enterobacteriaceae family, which are frequently overrepresented in inflammatory …

The impact of phytochemicals in obesity-related metabolic diseases: focus on ceramide metabolism

E Kim, S Jeon - Nutrients, 2023 - mdpi.com
The prevalence of obesity and related metabolic diseases has increased dramatically
worldwide. As obesity progresses, various lipid species accumulate in ectopic tissues …